Susquehanna International Group’s Genetic Technologies Ltd. GENE Stock Holding History

Susquehanna International Group’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,260	Closed	-$52K	–	14230
2022 Q1	$52K	Sell	5,260 -260	-5%	-$2.53K	﹤0.01%	12300
2021 Q4	$52K	Buy	+5,520	New	+$70.8K	﹤0.01%	12524
2021 Q3	–	Sell	-5,240	Closed	-$111K	–	13783
2021 Q2	$111K	Buy	+5,240	New	+$106K	﹤0.01%	12044
2020 Q4	–	Sell	-2,180	Closed	-$38K	–	11878
2020 Q3	$38K	Buy	+2,180	New	+$40.6K	﹤0.01%	10272
2015 Q2	–	Sell	-665	Closed	-$70K	–	10547
2015 Q1	$70K	Buy	+665	New	+$54.4K	﹤0.01%	9072

Other funds holding GENE

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Susquehanna International Group's GENE Position: Q4 2024 in Review

Susquehanna International Group sold out of Genetic Technologies Ltd. (GENE) in Q4 2024, closing a stake of 27,617 shares — an estimated $20.7K sold.

Susquehanna International Group first reported a position in GENE in Q2 2013 and held it in 25 quarters. The position peaked at $997K in Q4 2016. 1 fund tracked by Wall St. Rank holds GENE as of Q4 2024.

Susquehanna International Group reported no remaining Genetic Technologies Ltd. position as of Q4 2024 after selling out during the quarter.
Susquehanna International Group sold 27,617 Genetic Technologies Ltd. shares in Q4 2024, an estimated $20.7K.
Susquehanna International Group first reported a position in Genetic Technologies Ltd. in Q2 2013 and held it in 25 quarters.
Susquehanna International Group's Genetic Technologies Ltd. position peaked at $997K in Q4 2016.
1 fund tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.